Second, the present study identified a decrease in the levels of total cholesterol, triglycerides, total lipids, SGOT, SGPT, and glucose in the groups treated with MO, in both infusion and ethanolic extracts, compared to the NAFLD group without treatment. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.